Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04855656 |
| Title | Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors (MYTHIC) |
| Acronym | MYTHIC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Debiopharm International SA |
| Indications | |
| Therapies | |
| Age Groups: | child | senior | adult |
| Covered Countries | USA | GBR | ESP | DNK | CAN |